terça-feira, 6 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 23, 2026

Super Group Reports Financial Results for Fourth Quarter and Full Year 2025

View original at finance.yahoo.com
Super Group Reports Financial Results for Fourth Quarter and Full Year 2025 Revenue of $2.2 billion for the year and $578.3 million for the fourth quarter of 2025 Profit before tax of $355.9 million for the year and $95.1 million for the fourth quarter of 2025 Non-GAAP Adjusted EBITDA of $559.5 million for the year and…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Apricot transaction approval will strengthen ex-Africa sportsbook technology platform and position business well for years ahead

    80% confidence
  • Q4 was record-breaking period for monthly active customers, wagers, and deposits despite unfavorable sports outcomes late in quarter

    80% confidence
  • 2026 guidance of at least $2.55 billion total revenue and over $680 million Adjusted EBITDA reflects continued customer momentum, operating leverage, and disciplined capital allocation

    80% confidence
  • Preliminary financial results are unaudited and subject to change upon completion of audit

    80% confidence
  • Strong balance sheet with $513 million cash supported $156 million shareholder returns in 2025 plus $125 million special dividend

    80% confidence
  • 2025 was a standout year for Super Group with sharpened focus by exiting U.S. iGaming market and concentrating resources in countries with durable advantages, driving record customer growth

    80% confidence
  • 2025 demonstrated strength and scalability of Super Group's model with 22% revenue growth and 57% Adjusted EBITDA growth to impressive 25% margin

    80% confidence
  • Group intends to publish annual financial statements in early April 2026

    80% confidence

Citado nestas reportagens da Via News

O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com